The high price of false positives

Research output: Contribution to journalComment/debate

19 Scopus citations

Abstract

There is rapid expansion of newborn screening throughout the United States. A recent report from the American College of Medical Genetics has recommended a mechanism by which decisions are made about adding tests to the screening panel, and a core panel of 29 conditions has been recommended. Implementing such a program is a major undertaking in every state and involves not only the laboratory but also a number of diagnostic and follow-up services. It is essential to have laboratory programs in place to minimize false positive screening tests and at the same time communicate in the most effective manner possible about the nature of false positives.

Original languageEnglish (US)
Pages (from-to)180-183
Number of pages4
JournalMolecular Genetics and Metabolism
Volume87
Issue number3 SPEC. ISS.
DOIs
StatePublished - Mar 2006

    Fingerprint

Keywords

  • False positive tests
  • Federal advisory panels
  • Genetic testing
  • New technology
  • Newborn screening
  • Public health departments
  • Public policy

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this